0001203311-13-000092.txt : 20131114
0001203311-13-000092.hdr.sgml : 20131114
20131114190458
ACCESSION NUMBER: 0001203311-13-000092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131031
FILED AS OF DATE: 20131114
DATE AS OF CHANGE: 20131114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRACHMAN JONATHAN G
CENTRAL INDEX KEY: 0001588467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 131222034
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-10-31
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001588467
DRACHMAN JONATHAN G
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
CMO & EVP, R & D
Common Stock
2013-10-31
4
A
0
8100.0
0.0
A
51112
D
These shares represent restricted stock units and will be settled in common stock upon vesting.
Restricted stock units shall vest in full on October 31, 2016.
Amount of securities beneficially owned include 40,400 Restricted Stock Units subject to vesting.
Jonathan G. Drachman
2013-11-14